本页面由Tiger Trade Technology Pte. Ltd.提供服务

Revolution Medicines, Inc.

102.74
+2.952.96%
盘后102.740.00000.00%17:06 EST
成交量:180.14万
成交额:1.84亿
市值:198.62亿
市盈率:-19.78
高:103.69
开:99.58
低:98.38
收:99.79
52周最高:124.49
52周最低:29.17
股本:1.93亿
流通股本:1.65亿
量比:1.06
换手率:1.09%
股息:- -
股息率:- -
每股收益(TTM):-5.1931
每股收益(LYR):-3.5776
净资产收益率:-60.76%
总资产收益率:-32.29%
市净率:12.44
市盈率(LYR):-28.72

数据加载中...

2026/01/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/07

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/07

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/12/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/12/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/12/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/12/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/12/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/11/25

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/11/25

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/11/25

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/11/25

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/11/19

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/11/19

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/11/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/11/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/11/07

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/11/06

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/11/06

重要事件披露

Form 8-K - Current report
2025/10/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities